Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! Screen on your Watchlists and Portfolios with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Vermillion Inc (VRML)

Vermillion Inc (VRML)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 389,512
  • Shares Outstanding, K 97,378
  • Annual Sales, $ 4,540 K
  • Annual Income, $ -15,240 K
  • 60-Month Beta 3.47
  • Price/Sales 92.91
  • Price/Cash Flow N/A
  • Price/Book 73.46
Trade VRML with:
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm -0.17
  • Most Recent Earnings N/A on N/A
  • Latest Earnings Date 05/14/20
  • Annual Dividend & Yield 0.00 (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Price Performance

See More
Period Period Low Period High Performance
1-Month
1.90 +110.53%
on 05/14/20
5.78 -30.80%
on 06/10/20
+2.01 (+101.01%)
since 05/11/20
3-Month
0.53 +653.30%
on 03/16/20
5.78 -30.80%
on 06/10/20
+3.16 (+376.76%)
since 03/11/20
52-Week
0.35 +1,040.90%
on 10/10/19
5.78 -30.80%
on 06/10/20
+2.85 (+247.83%)
since 06/11/19

Most Recent Stories

More News
Aspira Women’s Health Inc. to Report First Quarter 2021 Financial Results on May 13

AUSTIN, Texas, May 05, 2021 (GLOBE NEWSWIRE) -- Aspira Women’s Health, Inc. (Nasdaq: AWH), a bioanalytical-based women’s health company, today announced that it will report financial results for...

VRML : 4.00 (-7.62%)
AWH : 3.49 (+1.16%)
Aspira Women’s Health, Inc. to Present at Cantor Virtual Healthcare Conference

AUSTIN, Texas, Sept. 08, 2020 (GLOBE NEWSWIRE) -- Aspira Women’s Health, Inc. (Nasdaq: AWH), a bioanalytical-based women’s health company, today announced management will participate in the 2020...

VRML : 4.00 (-7.62%)
AWH : 3.49 (+1.16%)
UPDATE – Aspira Women’s Health Reports Second Quarter 2020 Financial Results

Conference Call scheduled for today, August 13th at 4:30 p.m. ET

VRML : 4.00 (-7.62%)
AWH : 3.49 (+1.16%)
Aspira Women’s Health Reports Second Quarter 2020 Financial Results

Conference Call scheduled for today, August 13th at 4:30 p.m. ET

VRML : 4.00 (-7.62%)
AWH : 3.49 (+1.16%)
Aspira Women’s Health, Inc. to Report Second Quarter 2020 Financial Results on August 13th

AUSTIN, Texas, July 31, 2020 (GLOBE NEWSWIRE) -- Aspira Women’s Health, Inc. (Nasdaq: AWH), a bioanalytical-based women’s health company, today announced it will report financial results for the...

VRML : 4.00 (-7.62%)
AWH : 3.49 (+1.16%)
Aspira Women’s Health Inc. Announces Equity Financing of Approximately $11 Million

AUSTIN, Texas, July 01, 2020 (GLOBE NEWSWIRE) -- Aspira Women’s Health Inc. (Nasdaq: AWH) (“ASPIRA”), a bioanalytical-based women’s health company focused on gynecologic disease, today announced...

VRML : 4.00 (-7.62%)
AWH : 3.49 (+1.16%)
Vermillion, Inc. Announces Rebranding and Company Name Change to Aspira Women’s Health Inc.

AUSTIN, Texas, June 11, 2020 (GLOBE NEWSWIRE) -- Vermillion, Inc. (Nasdaq: VRML), a bioanalytical-based women’s health company focused on ovarian cancer risk assessment, today announced a major rebranding...

VRML : 4.00 (-7.62%)
Vermillion Completes Validation of New Pre-Surgical Test Offerings with OVA1®plus, including COVID-19 Antibody Testing and Additional Pelvic Mass Risk Assessment Biomarkers

AUSTIN, Texas, June 10, 2020 (GLOBE NEWSWIRE) -- Vermillion, Inc. (Nasdaq: VRML), a bioanalytical-based women’s health company focused on gynecologic disease, is excited to announce that its wholly-owned...

VRML : 4.00 (-7.62%)
Vermillion Set to Join Russell 3000® Index

AUSTIN, Texas, June 09, 2020 (GLOBE NEWSWIRE) -- Vermillion, Inc. (Nasdaq: VRML), a bioanalytical-based women’s health company focused on gynecologic disease, today announced that it is set to join...

VRML : 4.00 (-7.62%)
Vermillion Reports First Quarter 2020 Financial Results

Conference Call scheduled for today, May 14th at 4:30 p.m. ET

VRML : 4.00 (-7.62%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Buy with a Strengthening short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

Vermillion, Inc. is engaged in the discovery, development and commercialization of novel diagnostic tests that help physicians diagnose, treat and improve outcomes for patients. The Company has diagnostic programs in oncology, hematology, cardiology and women's health. Its tests are intended to guide...

See More

Key Turning Points

3rd Resistance Point N/A
2nd Resistance Point 4.57
1st Resistance Point 4.28
Last Price 4.00
1st Support Level 3.68
2nd Support Level 3.37
3rd Support Level N/A

See More

52-Week High 5.78
Last Price 4.00
Fibonacci 61.8% 3.71
Fibonacci 50% 3.07
Fibonacci 38.2% 2.42
52-Week Low 0.35

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar